Sitofibrate is a fibrate-class antihyperlipidemic agent primarily utilized in the management of hypercholesterolemia and hypertriglyceridemia, where it acts by inhibiting cholesterol synthesis and enhancing… Read more
Sitofibrate is a fibrate-class antihyperlipidemic agent primarily utilized in the management of hypercholesterolemia and hypertriglyceridemia, where it acts by inhibiting cholesterol synthesis and enhancing LDL receptor activity. This category encompasses high-quality Sitofibrate reference standards, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. Pharmaceutical and analytical laboratories rely on these specific materials to perform rigorous impurity profiling, method validation, and routine quality control of the active pharmaceutical ingredient. By utilizing these precise analytical tools, researchers can ensure accurate identification and quantification of degradation products or synthetic by-products throughout the drug development lifecycle. These standards are essential for maintaining regulatory compliance and confirming the purity and efficacy of formulations containing this cholesterol-lowering medication.